Table 3 First- and second-line treatment of elderly patients with hepatocellular carcinoma.

From: A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly

 

Second-line treatment

Total

Supportive care

Surgical resection

RFA

TACE

Chemotherapy

Radiation therapy

Radioembolization

Transplantation

Others

n

%

n

%

n

%

n

%

n

%

n

%

n

%

n

%

n

%

First-line treatment

Supportive care

868

100.00

                

868

Surgical resection

378

67.14

10

1.78

27

4.80

106

18.83

31

5.51

6

1.07

    

5

0.89

563

RFA

242

62.53

2

0.52

70

18.09

61

15.76

  

6

1.55

    

6

1.55

387

TACE

543

37.95

34

2.38

103

7.20

624

43.61

31

2.17

55

3.84

3

0.21

6

0.42

32

2.24

1431

Chemotherapy

141

80.11

1

0.57

1

0.57

4

2.27

13

7.39

15

8.52

    

1

0.57

176

Radiation therapy

25

65.79

1

2.63

  

2

5.26

7

18.42

3

7.89

      

38

Radioembolization

6

30.00

2

10.00

  

8

40.00

    

2

10.00

  

2

10.00

20

Transplantation

8

88.89

      

1

11.11

        

9

  1. RFA, radiofrequency ablation; TACE, transarterial chemoembolization; n, number; UICC, The Union for International Cancer Control; BCLC, Barcelona Clinic Liver Cancer.
Back to article page